Skip to main content
SpringerLink
Log in

Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study

  • RESEARCH LETTER
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

The data that support the findings of this study are available on request from the corresponding author, [WS].

References

  1. King BA, Craiglow BG (2023) Janus kinase inhibitors for alopecia areata. J Am Acad Dermatol 89(2s):S29-s32

    Article  CAS  PubMed  Google Scholar 

  2. Li SJ, Mostaghimi A, Tkachenko E, Huang KP (2019) Association of out-of-pocket health care costs and financial burden for patients with alopecia areata. JAMA Dermatol 155(4):493–494

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sinclair R (2022) Alopecia areata: progress, but who pays? Br J Dermatol 186(2):206–207

    Article  CAS  PubMed  Google Scholar 

  4. The LO (2018) Generic drugs: are they the future for affordable medicine? Lancet Oncol 19(2):149

    Article  Google Scholar 

Download references

Funding

None.

Author information

Author notes

  1. Jia Jian, Min Li have contributed equally to this work and share first authorship.

Authors and Affiliations

  1. Hu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China

    Jia Jian, Min Li, Pei Qian, Ji Li, Yan Tang, Fangfen Liu, Zhixiang Zhao, Jundong Huang & Wei Shi

Authors
  1. Jia Jian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Min Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pei Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ji Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yan Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fangfen Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhixiang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jundong Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wei Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the final manuscript. J-J and M-L collected the clinical data and drafted the manuscript. Corresponding authors W-S and JD-H read and revised the manuscript. All authors contributed to the article and approved the submitted version.

Corresponding authors

Correspondence to Jundong Huang or Wei Shi.

Ethics declarations

Conflict of interest

None declared.

Ethics statement

Reviewed and approved by the institutional research ethics boards of Xiangya Hospital, Central South University (Changsha, China); approval number: 202312240. The patients in this manuscript have given written informed consent to the publication of their case details. This study was also conducted in adherence to the STROBE guidelines.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 143 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jian, J., Li, M., Qian, P. et al. Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study. Arch Dermatol Res 316, 154 (2024). https://doi.org/10.1007/s00403-024-02879-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00403-024-02879-4

Keywords

Search

Navigation